Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
Pulmatrix is a clinical stage pharmaceutical company developing a broad new class of inhaled therapies that treat, prevent and help control infectious and progressive respiratory diseases.
Headlines from Mass High Tech about PULMATRIX INC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Year Established | 2006 |
| Ownership Type | Private |
| Robert Clarke | CEO | |||
| John Hanrahan | Chief Medical Officer/SVP | email available to subscribers | ||
| Molly Rosano | VP Clinical Operations | |||
| Eva Jack | Chief Business Officer |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Lexington, MA |
| Website | http://www.pulmatrix.com |
| Revenue | Subscriber access only |
| Address | 99 Hayden Ave Suite 390 Lexington, MA, 02421 |
| Phone | 781-357-2333 |
| Subscriber access only | |
| Website | www.pulmatrix.com |
© 2012 American City Business Journals. All rights reserved. Use of this Site constitutes acceptance of our User Agreement (updated 3/14/12) and Privacy Policy (updated 3/14/12).
Your California Privacy Rights.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of American City Business Journals.